Most Viewed Posts This Month

  1. 1
    KenChowder First: no guarantee there will be data on the AACR poster that wasn't in the abstract.  The last
    (21) 1,704
  2. 2
    ScoreCarder companies typically have a cutoff date that is a while before the conference.  cytodyn might have
    (5) 1,433
  3. 3
    ohm20 Here is a list of publications that I printed out for someone possibly seeking an EIND for breast
    (39) 1,157
  4. 4
    StinkyPennies There's a member of the private cydy Facebook group (who also happens to be a physician) who's
    (13) 1,076
  5. 5
    My69z CELLSEARCH 2020 mTNBC 130 page Protocol Mentions: CELLSEARCH® Circulating Tumor Cell (CTC)
    980
  6. 6
    ScoreCarder pretty sure the rollover was approved. they will get the ICI upon progression, or at 48 weeks.  
    (4) 979
  7. 7
    brentie Is this true? "Q3 2026 earnings will be released after the market closes on Tuesday, April 14,
    (1) 931
  8. 8
    Katangolo ESMO-Gastro might not be “gigantic” but the data presented last year on July 4 at noon by Dr.
    (4) 914
  9. 9
    brentie Interesting reply to a post from Ed Kim at City of Hope... Chris Wood, MHA• 3rd+ Experienced
    (16) 888
  10. 10
    twinter11  Looking at the CYDY MCRC abstract. I noticed the first 5 patients had zero CTC's and decreasing
    (12) 834
  11. 11
    Cydyforlife wow what an attack lol
    831
  12. 12
    biloxiblues The "speed" hurdle is being attacked by the FDA's new pilot programs, and the "Big Pharma" hurdle
    (12) 822
  13. 13
    docj CytoDyn to Present at the AACR Annual Meeting 2026 Download as PDFApril 14, 2026 8:30am EDT
    (9) 821
  14. 14
    sean007 "You do Not get to Bolt On a multibillion dollar ICI onto an active protocol halfway through the
    (9) 815
  15. 15
    twinter11 There is a line in the Pestell AACR Tnbc Abstract. I asked google what the different pdl1
    (20) 808
  16. 16
    skezan What universe are you living in? That was a concerted, timed attack.
    (3) 802
  17. 17
    postal lady “The company UNVC cannot legally or operationally claim both positions simultaneously”. I'm not
    (4) 798
  18. 18
    twinter11 I was going to copy the description of the biomarkers they called out in the coming mcrc abstract.
    (2) 792
  19. 19
    ScoreCarder AACR in 9 days? ORR data on 20+ patients is possible.  If enrollment was at a rate of 10 per month
    (5) 792
  20. 20
    Jake2212 As someone who has no regulatory, drug company, or medical/scientific background of any kind, but
    (19) 788
  21. 21
    Figgs   "show me a post where i say leron doesnt work or won't work."  How about THIS POST!  "it
    (8) 788
  22. 22
    twinter11 Looking forward to unveiling the first set of results on the????????phase-2 study! We call it
    (11) 787
  23. 23
    My69z Patent History Patent number: 12480952 Type: Grant Filed: Apr 26, 2022 Date of Patent: Nov 25,
    (8) 778
  24. 24
    Cydyforlife https://www.investing.com/equities/cyt
    (7) 769
  25. 25
    twinter11 I was speaking about the poster thats being released the coming 17th if there is
    766
  26. 26
    My69z 2x's the significance: Our initial mCRC data, starts to validate both companies patents
    (2) 764
  27. 27
    ScoreCarder crc trial is 1:1 dosage cohorts, 30@350 30@700 per the clinicaltrials entry.  i know there have
    (3) 753
  28. 28
    KenChowder All it would take is earnings of $75 million in the next week.  Can't see any problems with
    (6) 752
  29. 29
    My69z Venom-Induced Inflammation: Snake venoms (specifically from families like Viperidae and
    (10) 745
  30. 30
    My69z Cytodyn/Syneos/Creativ: Build this thing !! Non-toxic.Drug-Drug. Metastatic. Angiogenesis. No
    (3) 744
  31. 31
    ScoreCarder paired with a 5-fu though. 21st could be grand, but overall its still complicated.  its best to
    (3) 744
  32. 32
    Chasing Stars Still some final adjustments I am working on, but the new site is live. I'll be putting all of the
    (34) 741
  33. 33
    Jake2212 Ken: My AI source, Google/Gemini is saying that the Nov 18, 2025 CTC clinical trial data published
    (15) 739
  34. 34
    Plotinus Regarding below update to the protocol:These are pharmacokinetic parameters (pk), essentially a
    (21) 738
  35. 35
    ScoreCarder the share price and partnership do not require approvals.  that is what i stated, yesterday and
    (14) 737
  36. 36
    twinter11 Creatv Bio appears to have a good handle on prognosticating which patients are likely to have
    (5) 737
  37. 37
    skezan Sounds like something a short would say.
    (1) 734
  38. 38
    zeropoiko CYDY 3 Month steady climb. I like it.
    (3) 729
  39. 39
    Cydyforlife You mean 3pm EST and yeah that was a very shady post by him.  He’s so smart and knows so much
    (4) 728
  40. 40
    Respert24 There are reasons to select a specific drug to use in a trial with your own, but it doesn't
    (17) 728
  41. 41
    biloxiblues Why Women With Metastatic Triple Negative Breast Cancer Cannot Wait The median survival for
    (19) 727
  42. 42
    brentie At least now, anybody can read it. You don't need a subscription for this one.
    (4) 719
  43. 43
    Cydyforlife not really :)
    717
  44. 44
    Evil Rabbit If you’re just going to post AI slop, can you perhaps condense into less posts and make your
    (16) 716
  45. 45
    HHIGambler Looks good, David. Thanks!
    (6) 716
  46. 46
    Evil Rabbit Weird you posted this a few days ago.  the AACR presentation date for crc is Tuesday april
    (9) 712
  47. 47
    Normy I'm waiting for the moment with SC like the north korean spy on the online job interview on 60
    712
  48. 48
    twinter11 Ive been wondering why no PR for the TNBC EAU. Are they keeping it quiet to more closely control
    (2) 709
  49. 49
    Mr3Putt can this on get pinned?
    (6) 709
  50. 50
    My69z A new sensitive cell biomarker of solid tumors and viral infection is identified in blood. This
    (3) 704